liver function series|renal function series|glycometabolism series--Shanghai Juchuang Pharmaceutical

中文

Home
About us

Company profile History Culture R & D
Products

New products Featured Products Cooperation
Small package

Blood lipids, lipoprotein metabolism, cardiovascular risk factors Liver function Kidney function Myocardial function and myocardial zymogram Glucose metabolism, diabetes monitoring Gastric function Rheumatoid markers, acute infection markers Pancreatic function Lung function Metabolism Metabolism,free radical monitoring Coagulation, fibrinolysis Special proteins Ions, iron metabolism Bone diseases Tumor markers Urine biochemistry Multiple composite calibrators, quality control products
OEM products

Blood lipids, lipoprotein metabolism, cardiovascular risk factors Liver function Kidney function Myocardial function and myocardial zymogram Sugar metabolism Pancreatic function and prostate function Pulmonary and gastric function Infection and inflammatory markers Rheumatism, rheumatoid arthritis Coagulation function Immunoglobulin, specific proteins Ionic Metabolism and others Tumor markers
News

Company news Industry news
Human resources

Talent concept Career Vacancy
Contact us

中文 English

NO.	Product name	Method	Clinical Significance
1	Apolipoprotein A1 (ApoA1)	Immunoturbidimetry	Indicators of Anti-Atherosclerosis
2	Apolipoprotein A2 (ApoA2)	Immunoturbidimetry	For Pathogenesis Assessment of Coronary Heart Disease and Atherosclerosis
3	Apolipoprotein B (ApoB)	Immunoturbidimetry	For risk assessment of coronary heart disease and atherosclerosis
4	Apolipoprotein C-II (ApoC-II)	Immunoturbidimetry	Aids in preventing the development of cardiovascular disease
5	Apolipoprotein C-III (ApoC-III)	Immunoturbidimetry	Aids in the prevention of cardiovascular and cerebrovascular diseases
6	Apolipoprotein E (ApoE)	Immunoturbidimetry	Different genotypes of APOE are strongly associated with Alzheimer's disease (AD)
7	Homocysteine (HCY)	Enzymatic Cycling Kinetic	Independent risk factor for cerebral infarction, atherosclerosis and coronary heart disease.
8	Free Fatty Acid (NEFA)	Enzymatic	Aids in diagnosis of diabetes mellitus and observation of drug efficacy
9	Lipoprotein (LP-a)	Latex-enhanced Immunoturbidimetry	Can be used as a threshold for determining risk factors for cardiovascular and cerebrovascular diseases
10	High-density lipoprotein cholesterol (HDL-C)	Chemical clearance	Decreased HDL-C is a risk factor for hyperemic heart disease
11	Low-density lipoprotein cholesterol (LDL-C)	Chemical clearance	Positively correlated with cardiovascular disease
12	Triglycerides (TG)	GPO-PAP Enzymatic	Elevated TG is a risk factor for coronary atherosclerotic heart disease.
13	Total Cholesterol (CHOL)	COD-PAP Enzymatic	Important indicator of atherosclerosis
14	Angiotensin-converting enzyme (ACE)	FAPGG Substrate	Elevated ACE activity is a risk factor for myocardial infarction
15	Small and dense low-density lipoprotein cholesterol (sdLDL-C)	Direct Enzymatic	Risk factor for coronary heart disease
16	Lipoprotein-Associated Phospholipase A2 (LP-PLA2)	Enzyme Kinetics	New Indicators for Diagnosis, Evaluation and Monitoring of Cardiovascular Diseases
17	Lipoprotein-associated phospholipase A2 (LP-PLA2)	Latex-enhanced Immunoturbidimetry	New Indicator for Diagnosis, Evaluation and Monitoring of Cardiovascular Diseases
18	Phospholipids (PLIP)	Choline Oxidase	Important Indicator of Hyperthyroidism, Dystrophic Liver Cirrhosis
19	Lipoprotein residual cholesterol (RLP-C)	Direct Enzymatic	Important Risk Factor for Coronary Heart Disease
20	Creatine kinase isoenzyme (CKMB mass)	Latex-enhanced Immunoturbidimetry	Important indicator for clinical diagnosis of myocardial infarction
21	Myeloperoxidase (MPO)	Latex-enhanced Immunoturbidimetry	MPO Levels Associated with Risk of Stroke, Angina and Myocardial Infarction

Products